Demonstration of SLU7 as a new cancer target
Year: 2025
Type: article
Language: en
Topic: RNA Research and Splicing
Authors and affiliations:
raw_author_name: Carla Rojo
raw_affiliation_strings: Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain
raw_author_name: Aaron Otero
raw_affiliation_strings: Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain
raw_author_name: Maria Elizalde
raw_affiliation_strings: Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain
raw_author_name: Maria Azkona
raw_affiliation_strings: Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain
raw_author_name: Roberto Barbero
raw_affiliation_strings: Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), Madrid, Spain
raw_author_name: Maria U. Latasa
raw_affiliation_strings: Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain
raw_author_name: Iker Uriarte
raw_affiliation_strings: Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), Madrid, Spain
raw_author_name: Alvaro Gutierrez-Uzquiza
raw_affiliation_strings: Department of Biochemistry and Molecular Biology, Pharmacy Faculty, Complutense University of Madrid, Madrid, Spain
raw_author_name: Diego Alignani
raw_affiliation_strings: Flow Cytometry Core, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain
raw_author_name: Laura Guembe
raw_affiliation_strings: Morphology Core Facility, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain
raw_author_name: Amaia Lujambio
raw_affiliation_strings: Liver Cancer Program, Division of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA
raw_author_name: Fernando Pastor
raw_affiliation_strings: Therapeutic Innovation Program, Center for Applied Medical Research, University of Navarra, Pamplona, Spain
raw_author_name: Maite G. Fernández-Barrena
raw_affiliation_strings: Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), Madrid, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
raw_author_name: Matias A. Ávila
raw_affiliation_strings: Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), Madrid, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
raw_author_name: Maria Arechederra
raw_affiliation_strings: Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), Madrid, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain. Electronic address: macalderon@unav.es
raw_author_name: Carmen Berasain
raw_affiliation_strings: Hepatology Laboratory, Solid Tumors Program, CIMA, CCUN, University of Navarra, Pamplona, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, Carlos III Health Institute), Madrid, Spain. Electronic address: cberasain@unav.es